Abstract
The purpose of this study is to compare score systems used to estimate the risk for cardiovascular disease (CVD) in young patients with poorly controlled type 2 diabetes. Fifty-seven Latin American patients with type 2 diabetes, between the ages 18 and 45 years, were screened to participate in a clinical research study evaluating the effects of intensive insulin therapy on both traditional and nontraditional CVD risk factors. All women were premenopausal and had regular menstrual periods. Baseline reviews of cardiovascular (CV) risk scores, personal history, physical examination, and laboratory screening were performed. The Framingham Study Score system and the presence of features of the metabolic syndrome (MSyn) were recorded and compared. Both genders had a comparable number of features of the MSyn, whereas according to the Framingham Score System, men had a slightly higher risk of CVD. The Framingham Score system is not an accurate device to estimate risk of CVD in premenopausal women with type 2 diabetes mellitus, who otherwise have a multiple features of the MSyn. If used to estimate risk of CVD, the Framingham score system could underestimate the risk of CVD in both young men and women with type 2 diabetes mellitus.
References
May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Jul 1, 1991·Diabetes Care·S M HaffnerH P Hazuda
Feb 6, 1991·JAMA : the Journal of the American Medical Association·E L Barrett-ConnorS L Edelstein
Aug 1, 1998·JAMA : the Journal of the American Medical Association·M A WinklebyA N Varady
Aug 5, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K M Flegal, R P Troiano
Jul 16, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·F E von EybenR von Eyben
Sep 6, 2003·The American Journal of Cardiology·Willa A Hsueh, Manuel J Quiñones
Oct 1, 2003·Circulation·Steven Haffner, Heinrich Taegtmeyer
Oct 1, 2003·Circulation·Andreas FestaSteven M Haffner
Oct 22, 2003·Obesity Research·Earl S FordWayne H Giles
Nov 25, 2003·Obesity Research·A Enrique Caballero
Jan 13, 2004·The American Journal of Cardiology·Cynthia J GirmanUNKNOWN 4S Group and the AFCAPS/TexCAPS Research Group
Jan 28, 2004·Circulation·Scott M GrundyUNKNOWN National Heart, Lung, and Blood Institute
Feb 13, 2004·Progress in Cardiovascular Diseases·Suzanne R Steinbaum
Apr 6, 2004·Atherosclerosis·Earl S Ford
Jun 17, 2004·JAMA : the Journal of the American Medical Association·Allison A HedleyKatherine M Flegal
Jul 22, 2004·Current Diabetes Reports·A Enrique Caballero
Jul 28, 2004·Diabetes·Darcy B CarrSteven E Kahn
Oct 2, 2004·International Journal of Cardiology·Alexander TenenbaumEnrique Z Fisman
Oct 27, 2004·Cardiology Clinics·George A MensahPrakash C Deedwania
Jan 12, 2005·Journal of Diabetes and Its Complications·Annika DotevallAnnika Rosengren
Citations
Dec 17, 2014·Journal of Diabetes and Metabolic Disorders·Manouchehr NakhjavaniAlireza Esteghamati
Apr 16, 2013·Journal of Cutaneous Medicine and Surgery·Kim PappAndrew Vieira
Nov 20, 2016·Research in Nursing & Health·Tanya CohnLola Coke
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity